Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tamoxifen (Primary)
- Indications Breast cancer
- Focus Pharmacogenomic; Pharmacokinetics
- 03 Apr 2012 Biomarkers information updated
- 02 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2008 Status change